Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

0.2290
-0.0489-17.60%
Volume:751.40K
Turnover:175.85K
Market Cap:3.06M
PE:-0.05
High:0.2769
Open:0.2636
Low:0.2000
Close:0.2779
52wk High:11.00
52wk Low:0.0002
Shares:13.36M
Float Shares:3.40M
Volume Ratio:1.43
T/O Rate:22.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.9510
EPS(LYR):-14.8490
ROE:-1236.83%
ROA:-427.27%
PB:0.21
PE(LYR):-0.02

Loading ...

Jul 22, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 17, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 16, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 07, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 07, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 02, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 26, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 26, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 15, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Apr 03, 2020

Major Issues Report

8-K - Current report
Feb 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 11, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jan 24, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 17, 2020

Major Issues Report

8-K - Current report
Dec 12, 2019

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 14, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 15, 2019

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Oct 08, 2019

Major Issues Report

8-K - Current report
Sep 09, 2019

Major Issues Report

8-K - Current report